Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 341 - 360 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17 18  19  20  21  22  23  24  25 »
Reset 

Tiziana Life Sciences Announces New Quantitative PET Imaging Data on Foralumab at the Annual Meeting of the American Academy of Neurology

Read more ››
By: GlobeNewswire - 18 Apr 2024

TG Therapeutics Awarded National Contract by the Department of Veterans Affairs for BRIUMVI as the Preferred Anti-CD20 for Relapsing Forms of Multiple Sclerosis

Read more ››
By: GlobeNewswire - 18 Apr 2024
Related companies:  TG Therapeutics, Inc.

Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 Million

Read more ››
By: GlobeNewswire - 18 Apr 2024
Related companies:  Benitec Biopharma Inc.

SpringWorks Therapeutics to Report First Quarter 2024 Financial Results Thursday, May 2, 2024

Read more ››
By: GlobeNewswire - 18 Apr 2024
Related companies:  SpringWorks Therapeutics Inc.

The Joint Corp. to Host Conference Call on Thursday, May 2nd to Discuss First Quarter 2024 Results

Read more ››
By: GlobeNewswire - 18 Apr 2024

Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a Study

Read more ››
By: GlobeNewswire - 18 Apr 2024
Related companies:  Benitec Biopharma Inc.

TG Therapeutics Announces Additional Data Presentations for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting

Read more ››
By: GlobeNewswire - 18 Apr 2024
Related companies:  TG Therapeutics, Inc.

Paratek Pharmaceuticals Presenting New Data from NUZYRA® (Omadacycline) and Investigator-Initiated Pre-Clinical Studies at European Society of Clinical Microbiology & Infectious Diseases Global (ESCMID Global) 2024

Read more ››
By: GlobeNewswire - 18 Apr 2024
Related companies:  Paratek Pharmaceuticals, Inc.

Arbutus to Report First Quarter 2024 Financial Results and Provide Corporate Update

Read more ››
By: GlobeNewswire - 18 Apr 2024
Related companies:  Arbutus Biopharma Corporation

Ardelyx to Report First Quarter 2024 Financial Results on May 2, 2024

Read more ››
By: GlobeNewswire - 18 Apr 2024
Related companies:  Ardelyx, Inc

Panbela Announces Poster Presentation at American Association for Cancer Research:

Read more ››
By: GlobeNewswire - 18 Apr 2024
Related companies:  Panbela Therapeutics, Inc.

American Shared Hospital Services Strengthens Senior Management Structure

Read more ››
By: GlobeNewswire - 18 Apr 2024
Related companies:  Advanced Medical Solutions Group plc | Van Lanschot

Immutep Appoints Leading Research Institute to Conduct First-in-Human Phase I Study of IMP761

Read more ››
By: GlobeNewswire - 18 Apr 2024
Related companies:  Immutep Limited

Volta Medical Announces Presentations at Heart Rhythm Society 2024 in Boston, MA, USA

Read more ››
By: GlobeNewswire - 18 Apr 2024
Related companies:  Volta Medical

23andMe announces CEO’s intention to pursue a potential take-private

Read more ››
By: GlobeNewswire - 18 Apr 2024
Related companies:  23andMe, Inc.

Monopar Announces Radiopharma Presentation Selected for Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting

Read more ››
By: GlobeNewswire - 18 Apr 2024
Related companies:  Monopar Therapeutics, Inc.

Canadian Men's Health Foundation names Kenton Boston as President & CEO

Read more ››
By: GlobeNewswire - 18 Apr 2024

Montauk Brewing’s Project 4:20 IPA Returns to Support Surfrider Foundation

Read more ››
By: GlobeNewswire - 18 Apr 2024
Related companies:  Tilray Inc.

BioVie to Present Data Showing How NE3107 Potentially Restores Homeostasis via Specific Genes Associated with Dementia, Metabolism, and Inflammation

Read more ››
By: GlobeNewswire - 18 Apr 2024
Related companies:  BioVie Inc.

Windtree Therapeutics Announces Reverse Stock Split

Read more ››
By: GlobeNewswire - 18 Apr 2024
Related companies:  Windtree Therapeutics, Inc.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17 18  19  20  21  22  23  24  25 »
to the top ↑